Madrigal's 15min chart sees KDJ Death Cross, Bearish Marubozu

lunes, 22 de septiembre de 2025, 12:02 pm ET1 min de lectura
MDGL--

Madrigal's 15-minute chart recently triggered a KDJ Death Cross and a Bearish Marubozu at 09/22/2025 12:00, indicating a shift in the momentum of the stock price towards the downside. This suggests that the potential for further decreases in the stock price is high, as sellers are currently in control of the market. Furthermore, the bearish momentum is likely to persist.

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) recently granted equity awards to 76 new non-executive employees, according to a press release dated September 18, 2025 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - September 18, 2025[1]. The awards, approved by the company's independent Compensation Committee, include options to purchase 2,015 shares of common stock and 31,821 time-based restricted stock units, with a total exercise price of $425.60 per share. The equity awards are part of Madrigal's 2025 Inducement Plan and are subject to continued employment Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)[2].

The equity awards are intended to incentivize employees and are granted as inducement material for their acceptance of employment with the company. Options vest 25% after one year, followed by 6.25% quarterly thereafter. Restricted stock units vest in four equal annual installments Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)[2].

In addition to these developments, Madrigal Pharmaceuticals' stock has shown a significant shift in momentum. On September 22, 2025, at 12:00, the 15-minute chart triggered a KDJ Death Cross and a Bearish Marubozu, indicating a potential downtrend in the stock price . This suggests that the current market sentiment is bearish, with sellers in control. The bearish momentum is likely to persist, potentially leading to further decreases in the stock price.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios